Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Spratt

Showing results (21-30 of 497) with videos related to

Pageof 50
Sort By:
The Lancet. Oncology|June 10, 2026
Preliminary results from PRIMARY2: bringing colour to a grey arenaDaniel E Spratt
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Breast and Prostate Cancer: Lessons to Be SharedDaniel E Spratt, Reshma Jagsi
Oncotargets and Therapy|November 3, 2012
Current and emerging treatment options for nasopharyngeal carcinomaDaniel E Spratt, Nancy Lee
Cancer Research|December 15, 2019
RadioGx: A New Preclinical Tool to Model Intrinsic RadiosensitivityDaniel E Spratt, Corey Speers
International Journal of Radiation Oncology, Biology, Physics|May 11, 2020
Challenging the Norm: What Level of Evidence Is Necessary to Adopt Postprostatectomy Hypofractionated Radiation Therapy?Himanshu Nagar, Daniel E Spratt
The Lancet. Oncology|January 8, 2020
Androgen deprivation therapy plus salvage radiotherapy after prostatectomySamuel Birer, Daniel E Spratt
International Journal of Radiation Oncology, Biology, Physics|August 4, 2021
Prostate SBRT Dose Escalation (9 Gy × 5, 13.3 Gy × 3, 24 Gy × 1): Are We Making Progress?Himanshu Nagar, Daniel E Spratt
International Journal of Radiation Oncology, Biology, Physics|June 5, 2021
Dose Escalation for Oligometastatic Disease: Is More Better?Tithi Biswas, Daniel E Spratt
Prostate Cancer and Prostatic Diseases|July 13, 2021
Drivers of racial disparities in prostate cancer trial enrollmentRandy Vince, Daniel E Spratt
Academic Medicine : Journal of the Association of American Medical Colleges|January 1, 2010
Locked-in: listening to save a lifeDaniel E Spratt, Michael Richardson
Pageof 50

Showing results (21-30 of 497) with videos related to

Sort By:
Pageof 50
The Lancet. Oncology|June 10, 2026
Preliminary results from PRIMARY2: bringing colour to a grey arenaDaniel E Spratt
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Breast and Prostate Cancer: Lessons to Be SharedDaniel E Spratt, Reshma Jagsi
Oncotargets and Therapy|November 3, 2012
Current and emerging treatment options for nasopharyngeal carcinomaDaniel E Spratt, Nancy Lee
Cancer Research|December 15, 2019
RadioGx: A New Preclinical Tool to Model Intrinsic RadiosensitivityDaniel E Spratt, Corey Speers
International Journal of Radiation Oncology, Biology, Physics|May 11, 2020
Challenging the Norm: What Level of Evidence Is Necessary to Adopt Postprostatectomy Hypofractionated Radiation Therapy?Himanshu Nagar, Daniel E Spratt
The Lancet. Oncology|January 8, 2020
Androgen deprivation therapy plus salvage radiotherapy after prostatectomySamuel Birer, Daniel E Spratt
International Journal of Radiation Oncology, Biology, Physics|August 4, 2021
Prostate SBRT Dose Escalation (9 Gy × 5, 13.3 Gy × 3, 24 Gy × 1): Are We Making Progress?Himanshu Nagar, Daniel E Spratt
International Journal of Radiation Oncology, Biology, Physics|June 5, 2021
Dose Escalation for Oligometastatic Disease: Is More Better?Tithi Biswas, Daniel E Spratt
Prostate Cancer and Prostatic Diseases|July 13, 2021
Drivers of racial disparities in prostate cancer trial enrollmentRandy Vince, Daniel E Spratt
Academic Medicine : Journal of the Association of American Medical Colleges|January 1, 2010
Locked-in: listening to save a lifeDaniel E Spratt, Michael Richardson
Pageof 50